Abstract
Extensive experimental evidence has confirmed that the early events of ischemia-induced neuronal damage are characterized by excessive influx of calcium [13, 14]. Activation of calcium-dependent enzymes such as protein kinase C, calmodulin (CaM) kinase II, calpain I, calcineurin, and phospholipase A2 is believed to play a major role in neuronal excitotoxicity [2, 4, 5, 16]. In addition, therapeutic intervention with agents which target either voltage- or receptor-mediated ion channels are found to have neuroprotective affects in animal models of focal and global ischemia [6, 7, 12, 14]. Despite these findings, the results of clinical therapeutic trials using these agents have thus far been inconclusive in human stroke patients [1]. Possible explanations for these results include differences in vulnerability between human and animal neurons, lower dose tolerance due to coexisting cardiovascular disease, and insensitivity in methods of detecting modest neuronal protection in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Nimodipine Study Group (1992) Clinical trial of nimodipine in acute ischemic stroke. Stroke 23: 3–8
Aronowski J, Grotta JC, Waxham MN (1992) Ischemia-induced translocation of Ca/calmodulin–dependent protein kinase II: potential role in neuronal damage. J Neurochem 58: 1743–1753
Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W (1988) Focal brain ischemia in the rat: method for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8: 474–485
Choi DW (1990) Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 10 (8): 2493–2501
DeGraba TJ, Aronowski J, Waxham N, Grotta JC (1991) Calcium influx and CaM-kinase II activity as predictors of neuronal damage. J Cereb Blood Flow Metab 11 Suppl 2:S–521
Grotta JC (1987) Current medical and surgical therapy for cerebrovascular disease. N Engl J Med 317: 1505–1515
Grotta JC, Picone CM, Ostrow PT, Strong RA, Rhoades HM, Earls RM, Yao LP, Dedman JR (1990) CGS–19755, a competitive NMDA receptor antagonist, reduces calciumcalmodulin binding and improves outcome after global cerebral ischemia. Ann Neurol 27: 612–619
Jacewicz M, Kiessling M, Pulsinelli WA (1986) Selective gene expression in focal cerebral ischemia. J Cereb Blood Flow Metab 6: 263–272
Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang XJ, Pulsinelli W (1991) Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 22: 1032–1039
Mies G, Ishimaru S, Xie Y, Soe K, Hossmann K-A (1991) Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 11: 753–761
Picone CM, Grotta JC, Earls R, Strong R, Dedman J (1989) Immunohistochemical determination of calcium–calmodulin binding predicts neuronal damage after global ischemia. J Cereb Blood Flow Metab 9: 805–811
Simon R, Shiraishi K (1990) N-Methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann Neurol 27: 606–611
Uematsu D, Araki N, Greenberg JH, Sladky J, Reivich M (1991) Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology 41: 88–94
Wieloch T, Siesjo BK (1982) Ischemic brain injury: the importance of calcium, lipolytic activities, and free fatty acids. Pathol Biol (Paris) 20: 269–277
Zivin JA, Mazzarella (1991) Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol 48: 1235–1238
Zivin JA, Kochhar A, Saitoh T (1990) Protein phosphorylation during ischemia. Stroke 21 Suppl 3: 117–121
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
De Graba, T.J., Grotta, J.C. (1994). Threshold of Calcium Influx After Global and Focal Ischemia: Implications for the Window of Therapeutic Opportunity. In: Hartmann, A., Yatsu, F., Kuschinsky, W. (eds) Cerebral Ischemia and Basic Mechanisms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78151-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-78151-3_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78153-7
Online ISBN: 978-3-642-78151-3
eBook Packages: Springer Book Archive